Clinical Trial Update: Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating exercise as a supportive measure for patients receiving checkpoint inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PD-1 Antibodies

Snippet

Sponsor: University Hospital Heidelberg | Conditions: PD-1 Antibodies, Exercise | Phase 2 | Status: COMPLETED